financetom
SNDX
financetom
/
Healthcare
/
SNDX
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Syndax Pharmaceuticals, Inc.SNDX
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 for the treatment of KMT2A rearranged (KMT2Ar) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD).

The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat.

Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

Latest News >
US watchdog criticizes FAA oversight of Boeing production
US watchdog criticizes FAA oversight of Boeing production
Oct 11, 2024
Oct 11 (Reuters) - A federal watchdog on Friday criticized the Federal Aviation Administration's oversight of Boeing ( BA ) airplane production, saying it does not have an effective system to oversee the planemaker's individual manufacturing facilities. The Transportation Department's Office of Inspector General said in a report the FAA's current audit processes are not comprehensive enough to adequately identify...
National Bank Previews Quebecor's Q3
National Bank Previews Quebecor's Q3
Oct 11, 2024
11:00 AM EDT, 10/11/2024 (MT Newswires) -- In his preview of Quebecor's third quarter results, National Bank analyst Adam Shine is looking for revenue of $1380 million (was $1406 million) and Adj. EPS $0.79 (was $0.86). According to Shine, the third quarter has three components to highlight: 1) better wireless loading, 2) pushing back against aggressive Internet discounting by Bell...
What's Happening With AGBA Stock?
What's Happening With AGBA Stock?
Oct 11, 2024
AGBA Group Holding Limited ( AGBA ) shares are trading higher Friday after the company announced that all steps have been finalized to move towards the completion of its merger with Triller Corp. The Details: The merger is expected to take place on Oct.14, subject to final Nasdaq approval, and will include a 4-to-1 reverse stock split of Agba (...
Lula slams US request for information on Brazil fighter jet deal
Lula slams US request for information on Brazil fighter jet deal
Oct 11, 2024
SAO PAULO, Oct 11 (Reuters) - Brazilian President Luiz Inacio Lula da Silva said on Friday it made no sense for the U.S. Department of Justice to request information from Saab over Brazil's purchase of the Swedish firm's Gripen fighter jets in 2014. Saab revealed the U.S. request on Thursday and said it intended to comply, without providing further details,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved